The United States patent system is at an inflection point. For over a decade, patent eligibility doctrine under 35 U.S.C. §101 has drifted into uncertainty, producing inconsistent judicial outcomes and eroding the reliability of patent rights in critical areas of innovation. The Patent Eligibility Restoration Act (PERA) offers a clear legislative solution. But its passage is far from guaranteed.

For patent owners, this is not an abstract policy debate—it is an economic imperative. PERA represents a rare opportunity to restore the foundational link between intellectual property and capital formation. Without decisive engagement from those most affected, that opportunity may be lost.

The Economic Stakes: Patent Rights as Investment Infrastructure

Patents are not merely legal protections; they are economic infrastructure. They enable the transformation of uncertain, high-cost research into investable assets. In sectors where development costs are substantial and replication is easy—biotechnology, diagnostics, artificial intelligence—patents are often the only mechanism that allows innovators to capture value.

The economic logic is well understood. Innovation requires upfront investment, often at significant scale. Yet without exclusivity, competitors can appropriate the resulting knowledge at minimal cost. This dynamic produces chronic underinvestment absent a system of enforceable rights. Patents solve this problem by creating temporary exclusivity, allowing innovators and their investors to earn returns commensurate with risk.  But this system depends on predictability. Investors must be able to assess whether patent protection will be available and enforceable. When that predictability erodes, so too does the willingness to invest.

The §101 Problem: From Legal Ambiguity to Economic Distortion

Over the past decade, the Supreme Court's decisions in Mayo, Alice, and related cases have fundamentally altered the landscape of patent eligibility. The resulting framework—built on concepts such as “abstract ideas” and “natural laws”—has proven difficult to apply consistently. Lower courts have struggled, producing outcomes that are often unpredictable and, in many cases, contradictory.  For patent owners, the consequences are immediate and material. Entire categories of innovation—particularly in diagnostics and software-enabled technologies—face heightened risk of ineligibility. Patents that once would have been granted and enforced are now routinely invalidated at early stages of litigation.  The economic effects are profound. When patent protection becomes uncertain, the expected return on innovation declines. This is not a theoretical concern. Venture capital has demonstrably retreated from areas such as diagnostic medicine, where eligibility risks are acute. Projects that require substantial upfront investment but lack reliable protection are increasingly viewed as nonviable.  The result is a growing pool of “missing innovation”—technologies that are never developed because the incentive structure no longer supports them. These losses are largely invisible, but their cumulative impact on economic growth is significant.

PERA's Economic Function: Restoring Expected Value

PERA directly addresses this breakdown by replacing judicially created exceptions with a clearer statutory framework. Its primary economic effect is to restore the exclusivity component of innovation returns. At a basic level, the value of an innovation project depends on three factors: the probability of technical success, the market value of the resulting product, and the degree of exclusivity that protects it. Current §101 doctrine has weakened or eliminated that third factor in many domains. PERA restores it. For patent owners, this restoration is critical. It means that successful inventions are once again more likely to yield enforceable rights. For investors, it means that expected returns can be modeled with greater confidence. For the economy as a whole, it means that more projects cross the threshold from concept to commercialization. This effect is particularly pronounced in high-fixed-cost industries. In biotechnology and diagnostics, development costs are substantial, while replication costs are low. Without patents, competitors can rapidly erode margins, undermining the economic viability of innovation. PERA corrects this imbalance by reestablishing reliable exclusivity.

Reinvigorating the Innovation Pipeline

The implications extend beyond individual firms. Patent eligibility uncertainty has had a chilling effect on the broader innovation ecosystem, particularly at the early stages. Venture capital, which depends heavily on intellectual property as a source of defensible value, has shifted away from areas where patents are unreliable. PERA has the potential to reverse this trend. By restoring clarity and predictability, it would reopen entire sectors to investment. Startups that are currently deemed too risky due to eligibility concerns would once again become viable. Universities and research institutions would find greater commercial pathways for their discoveries. The result would be a more dynamic and diverse innovation pipeline. In this sense, PERA is not merely a patent reform—it is a mechanism for improving capital allocation across the economy.

Strategic Competitiveness: Keeping Innovation in the United States

The global context underscores the urgency of reform. Other jurisdictions, including Europe and China, have adopted more predictable or expansive approaches to patent eligibility in certain areas. As a result, the United States risks ceding leadership in critical technologies. Innovation is mobile. Capital, talent, and research activity will flow to environments where legal frameworks support commercialization. If the U.S. continues to offer a comparatively uncertain patent regime, it will increasingly lose ground in sectors that are central to future economic growth. PERA provides a means of restoring the United States' competitive position. By ensuring that innovators can secure and enforce rights domestically, it reinforces the country's role as a global leader in technology and research.

Reducing Friction, Increasing Efficiency

            Beyond its impact on investment, PERA would reduce the transaction costs associated with legal uncertainty. Under the current system, patent owners often face prolonged litigation over eligibility before reaching substantive issues such as infringement or validity. This inefficiency imposes real costs:

• Resources diverted from innovation to legal disputes
• Delays in bringing products to market
• Increased barriers for smaller entities lacking litigation resources

By clarifying eligibility standards, PERA would streamline the system, allowing disputes to focus on the merits of inventions rather than threshold questions.

The Political Reality: Why PERA Has Not Yet Passed

Despite its economic merits, PERA has repeatedly stalled. The central obstacle is not legal complexity but political risk. Opponents, particularly large operating companies, argue that expanding eligibility will lead to increased litigation and a resurgence of non-practicing entity activity. These concerns, whether justified or not, have shaped the legislative environment. Lawmakers are wary of reforms that could be framed as enabling abusive litigation. As a result, PERA has struggled to build the broad coalition necessary for passage.

A Call to Action for Patent Owners

For patent owners, the lesson is clear: PERA will not pass without active engagement from those who stand to benefit most.  This engagement must take several forms:

1) Reframing the Narrative

The debate must move beyond abstract legal doctrine. Patent owners must emphasize the real economic consequences of the current system:

• lost investment
• abandoned research
• diminished competitiveness

PERA should be framed as a growth and innovation measure, not a technical fix.

2) Addressing Legitimate Concerns

To build support, proponents must engage constructively with concerns about litigation. This may involve supporting complementary reforms or clarifying how existing safeguards—such as novelty and non-obviousness—will continue to prevent low-quality patents.

3) Expanding the Coalition

Success will require a broader base of support. Patent owners must work to include:

• emerging technology companies
• research institutions
• investors and venture capital firms

A diverse coalition signals that PERA serves the broader economy, not a narrow set of interests.

4) Direct Legislative Engagement

Ultimately, legislative outcomes depend on sustained advocacy. Patent owners should engage directly with policymakers, providing concrete examples of how current eligibility doctrine has affected investment decisions and innovation outcomes.  Silence, in this context, is not neutral—it is a barrier to reform.

Conclusion

The Patent Eligibility Restoration Act offers a path to restoring the economic function of the U.S. patent system. By reestablishing predictable and enforceable rights, it would unlock investment, strengthen the innovation pipeline, and enhance global competitiveness. For patent owners, the stakes are clear. The current trajectory of §101 doctrine undermines the very foundation of patent-based innovation. PERA provides an opportunity to correct course—but only if those with the most to gain are willing to act. The question is no longer whether reform is needed. It is whether the patent community will seize this moment to ensure that reform occurs. 

Ramey LLP is a Texas-based intellectual property law firm dedicated to representing small patent owners, startups, and independent inventors in disputes against larger corporations.